Anodyne Nanotech

Boston, MA · Founded 2019 · Privately Held (backing)

Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. Anodyne Nanotech is based in Boston, MA and was founded in 2019. Its last reported valuation was $7 million in Aug 2020. It has raised $9.6 million across 3 recorded rounds; the latest was a $12.6 million early-stage round in May 2026.

Last reported valuation
$7.0M
Oct 2026
Priced at
—
Total raised
$9.6M
Last round
Early Stage VC
May 2026

Who backs Anodyne Nanotech?

7 investors
InvestorType
Bantam GroupAngel
Endeavor GreeceOther
Big Pi Ventures—
New Ventures Pitch Competition—
Relativity Healthcare Partners—
Tufts University—
Velocity Partner—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Anodyne Nanotech investors

7 investors are on record for Anodyne Nanotech, including Bantam Group, Endeavor Greece, Big Pi Ventures and New Ventures Pitch Competition. The early-stage round in May 2026 drew 47 investors.

Free account
More of Anodyne Nanotech with a free account
  • ·Watch Anodyne Nanotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Anodyne Nanotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View